Patients on high doses of a popular weight-loss drug shed fewer pounds than those on a lower dose, a study has found.

Ongoing research is needed to fully understand their risks, especially for long-term and higher-dose users. However, many ...

As weight loss drugs like Ozempic and Wegovy skyrocket in popularity, new research is revealing a darker side. While these ...

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

LynFit Nutrition is a recurring segment featured on“CT BUZZ,” where Metabolic Weight Loss & Fat Burning Expert, Lisa Lynn, ...

Wegovy® is indicated for chronic weight management in adults and adolescents (12+) with obesity or overweight and at least one related health condition. The once-weekly injectable supports weight loss ...

The new arrangement could cut patients' copays to $25 per month, or less, for Wegovy, Zepbound, Ozempic and Rybelsus ...

In a recent panel conversation, healthcare and industry experts discussed where to find reliable guidance in a sea of ...

Some users of weight loss jabs have reported losing more than just the pounds-they've taken to online forums in their ...

Animal studies support that theory. GLP-1 drugs reduce inflammation in the brain and interfere with reward pathways linked to ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Experts are warning anyone experiencing GLP-1 drug side effects to report them after launching an investigation into their safety.